Application of multiple statistical tests to enhance mass spectrometry-based biomarker discovery
暂无分享,去创建一个
Kevin P. Rosenblatt | Harold R. Garner | Wayne G. Fisher | Niclas Chiang Tan | K. Rosenblatt | H. Garner | W. Fisher | N. C. Tan
[1] David A Bennett,et al. High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. , 2005, Clinical chemistry.
[2] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] Michael Aldrich,et al. Reduced Number of Hypocretin Neurons in Human Narcolepsy , 2000, Neuron.
[4] Shinto Eguchi,et al. Identification of biomarkers from mass spectrometry data using a "common" peak approach , 2006, BMC Bioinformatics.
[5] T. Young,et al. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. , 2006, Brain : a journal of neurology.
[6] Kevin P. Rosenblatt,et al. A Robust Biomarker Discovery Pipeline for High-Performance Mass Spectrometry Data , 2007, J. Bioinform. Comput. Biol..
[7] E. Shtatland,et al. THE PERILS OF STEPWISE LOGISTIC REGRESSION AND HOW TO ESCAPE THEM USING INFORMATION CRITERIA AND THE OUTPUT DELIVERY SYSTEM , 2001 .
[8] David Ward,et al. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data , 2003, Bioinform..
[9] J. Albrethsen. Reproducibility in protein profiling by MALDI-TOF mass spectrometry. , 2007, Clinical chemistry.
[10] Chong Ho Yu,et al. An Overview of Remedial Tools for Collinearity in SAS , 2000 .
[11] A. Pothen,et al. Protocols for disease classification from mass spectrometry data , 2003, Proteomics.
[12] G. Li,et al. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers , 2002, Bioinform..
[13] M. Girolami,et al. Clinical proteomics: A need to define the field and to begin to set adequate standards , 2007, Proteomics. Clinical applications.
[14] Habtom W. Ressom,et al. Analysis of mass spectral serum profiles for biomarker selection , 2005, Bioinform..
[15] G. Hortin. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? , 2005, Clinical chemistry.
[16] Richard Baumgartner,et al. Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions , 2003, Bioinform..
[17] Jean-François Hocquette,et al. Assessment of hierarchical clustering methodologies for proteomic data mining. , 2007, Journal of proteome research.
[18] H. Otu,et al. Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling , 2005, Clinical chemistry and laboratory medicine.
[19] J. Siegel,et al. Narp immunostaining of human hypocretin (orexin) neurons , 2005, Neurology.
[20] Susmita Datta,et al. Comparisons and validation of statistical clustering techniques for microarray gene expression data , 2003, Bioinform..
[21] David W. Hosmer,et al. Applied Logistic Regression , 1991 .
[22] E. Mignot,et al. Narcolepsy with cataplexy , 2007, The Lancet.